Order Article Reprints

Hussaarts KGAM, van Doorn L, Eechoute K, Damman J, Fu Q, van Doorn N, Eisenmann ED, Gibson AA, Oomen-de Hoop E, de Bruijn P, et al. Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib. Pharmaceutics. 2020; 12(9):788. https://doi.org/10.3390/pharmaceutics12090788

Hussaarts, Koen G. A. M., Leni van Doorn, Karel Eechoute, Jeffrey Damman, Qiang Fu, Nadia van Doorn, Eric D. Eisenmann, Alice A. Gibson, Esther Oomen-de Hoop, Peter de Bruijn, and et al. 2020. "Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib" Pharmaceutics 12, no. 9: 788. https://doi.org/10.3390/pharmaceutics12090788

Hussaarts, K. G. A. M., van Doorn, L., Eechoute, K., Damman, J., Fu, Q., van Doorn, N., Eisenmann, E. D., Gibson, A. A., Oomen-de Hoop, E., de Bruijn, P., Baker, S. D., Koolen, S. L. W., van Gelder, T., van Leeuwen, R. W. F., Mathijssen, R. H. J., Sparreboom, A., & Bins, S. (2020). Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib. Pharmaceutics, 12(9), 788. https://doi.org/10.3390/pharmaceutics12090788